The Federal Trade Commission is on a roll in its attack on what it considers anti-competitive effects in the healthcare industry. And that roll has consistently involved challenging activity that once appeared to be protected...more
Antitrust investigations are no longer limited to a nation’s borders, or even to a region. Enforcers are more and more sharing information and coordinating their investigative efforts as they strive to uniformly enforce the...more
In a vote of three to two, with voting falling along political party lines, the Federal Communications Commission approved an order addressing 21 pending petitions seeking clarifications of various aspects of the Telephone...more
For the first time since 2009, the FTC has updated the Q&A on its Endorsement Guides. The Endorsement Guides represent administrative interpretations of laws enforced by the FTC, specifically the applicability of Section 5...more
Do you sit on a state board or are you regulated by one? If so, the United States Supreme Court decided a case last Wednesday that directly affects you.
Until recently, many assumed that a state agency or board enjoyed...more
Are you a practicing physician who sits on a state licensing board? Is your business affected by a state board with practicing physicians on it?
If you said yes to either question, you should read on....more
In a much-anticipated decision, the Supreme Court in FTC v. Actavis held 5-3 that reverse-payment settlements of Hatch-Waxman Act litigation are neither immune from antitrust liability nor presumptively unlawful, but rather...more
The Supreme Court has issued its much-awaited decision in FTC v. Actavis on the antitrust analysis of reverse-payment settlements of Hatch-Waxman Act litigation....more